Ten miRNAs have been selected to verify their effect on Tau levels MiR-92a-3p, miR-320a and miR-320b were selected to analyse their levels in plasma samples of patients with FTD and AD respect toHCs. This evidence concerns the gene MAPT and frontotemporal dementia.